📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Second MEK Inhibitor Shows Promise in Neurofibromatosis Type 1 With Symptomatic Plexiform Neurofibromas Signaling Hope for Other RASopathies. (2025)

First Author: Cook SJ

Attributed to: Signalling mechanisms that determine the rate of ageing funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco-24-02375

PubMed Identifier: 39661912

Publication URI: http://europepmc.org/abstract/MED/39661912

Type: Journal Article/Review

Volume: 43

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 6

ISSN: 0732-183X